The median b-wave amplitudes and implicit times were 38 µV and 33 ms (photopic cone-dominated response), 43 µV and 63 ms (5-min dark adaptation), 72 µV and 89 ms (10 min), 147 µV and 103 ms (15 min), 188 µV and 109 ms (20 min, 0.03 cd·s/m2, rod response), and 186 µV and 77 ms (20 min, 3 cd·s/m2, maximal combined rod-cone response). Thus, the objectives of this study were to compare the niacin status of EGS and control grazing horses.
A steady increase in amplitude and implicit time was noted during dark adaptation. The use of detomidine hydrochloride sedation and the DTL microfiber electrode allowed the recording of good quality ERGs. A secondary objective was to compare blood concentrations of vitamins B1, B2 and B6 in EGS and control grazing horses to determine if the status of these vitamins was altered in EGS.
Because of the difficulties in ensuring the accurate delivery of small doses, the product should only be used in horses of less than 200kg bodyweight in accordance with a benefit / risk assessment by the responsible veterinarian.
The syringe is brought into the animal’s mouth and the suitable dose is pumped into the cheek pouch. Not for use in animals in shock or post traumatically, or with existing severe emotional excitation or epilepsy.
The horses were sedated intravenously with detomidine hydrochloride (0.015 mg/kg).
The pupil was dilated and the auriculopalpebral nerve was blocked.
The simultaneous use of organic phosphate esters increases the toxicity of acepromazine.
Since acepromazine decreases sympathetic nervous system tone, it should not be given at the same time as blood pressure reducing drugs.
Acepromazine has caused paraphimosis sometimes in a sequel to priapism.
Acepromazine should not be used in pregnant or lactating mares.
Increasing the dose will increase the level of sedation and prolong the period of effect.
Yellow-orange transparent gel for oral administration. Each ml contains acepromazine (as acepromazine maleate) 35.0 mg and methyl-4-hydroxybenzoate 0.65 mg and propyl-4-hydroxybenzoate 0.35 mg as preservatives.
In stallions the lowest dose range is indicated to minimise prolapse of the penis.